BB
CEMP

BB Biotech’s Cempra, Inc. CEMP Stock Holding History

BB Biotech’s Portfolio CEMP Stock Details CEMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,041,900
Closed -$49.4M – 30
2016
Q3 		$49.4M Hold
2,041,900
– – 1.74% 15
2016
Q2 		$33.7M Hold
2,041,900
– – 1.33% 20
2016
Q1 		$35.8M Buy
2,041,900
+50,000
+3% +$907K 1.42% 18
2015
Q4 		$62M Buy
1,991,900
+100,000
+5% +$2.78M 1.75% 16
2015
Q3 		$52.7M Buy
1,891,900
+125,000
+7% +$4.64M 1.67% 17
2015
Q2 		$60.7M Buy
1,766,900
+543,900
+44% +$19.2M 1.65% 19
2015
Q1 		$42M Buy
1,223,000
+448,000
+58% +$13.5M 1.25% 23
2014
Q4 		$18.2M Buy
+775,000
New +$11.6M 0.59% 25

Other funds holding CEMP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
HCM
Hodges Capital Management Dallas, Texas $1.21B AUM 49% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

BB Biotech's CEMP Position: Q4 2016 in Review

BB Biotech sold out of Cempra, Inc. (CEMP) in Q4 2016, closing a stake of 2,041,900 shares — an estimated $49.4M sold.

BB Biotech first reported a position in CEMP in Q4 2014 and held it in 8 quarters. The position peaked at $62M in Q4 2015. 130 funds tracked by Wall St. Rank hold CEMP as of Q4 2016.

  • BB Biotech reported no remaining Cempra, Inc. position as of Q4 2016 after selling out during the quarter.
  • BB Biotech sold 2,041,900 Cempra, Inc. shares in Q4 2016, an estimated $49.4M.
  • BB Biotech first reported a position in Cempra, Inc. in Q4 2014 and held it in 8 quarters.
  • BB Biotech's Cempra, Inc. position peaked at $62M in Q4 2015.
  • 130 funds tracked by Wall St. Rank held Cempra, Inc. as of Q4 2016.

Based on BB Biotech's 13F filing for Q4 2016, filed 14 Feb 2017.